Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-12
DOI
10.3389/fneur.2019.01315
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel cystamine-core dendrimer-formulation rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection by augmenting autophagy
- (2019) Janine Faraj et al. Expert Opinion on Drug Delivery
- Visual and verbal learning and memory in cystinosis
- (2019) Alexandra M. Frankel et al. BRAIN AND COGNITION
- Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats
- (2019) Angelina Rakovska et al. BRAIN RESEARCH BULLETIN
- Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial
- (2019) F. Cicchetti et al. NEUROBIOLOGY OF DISEASE
- Gasotransmitter hydrogen sulfide signaling in neuronal health and disease
- (2018) Bindu D. Paul et al. BIOCHEMICAL PHARMACOLOGY
- Cysteine Metabolism in Neuronal Redox Homeostasis
- (2018) Bindu D. Paul et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Transglutaminase 2 Induces Deficits in Social Behavior in Mice
- (2018) Amanda Crider et al. NEURAL PLASTICITY
- Alzheimer's disease
- (2017) C. A. Lane et al. EUROPEAN JOURNAL OF NEUROLOGY
- Huntington's disease: a clinical review
- (2017) P. McColgan et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neurocognitive Complications of Cystinosis
- (2017) Doris Trauner JOURNAL OF PEDIATRICS
- Transglutaminases Derived from Astrocytes Accelerate Amyloid β Aggregation
- (2017) Kenji Kawabe et al. NEUROCHEMICAL RESEARCH
- Cystamine attenuated behavioral deficiency via increasing the expression of BDNF and activating PI3K/Akt signaling in 2,5-hexanedione intoxicated rats
- (2017) Shuo Wang et al. Toxicology Research
- A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury
- (2016) Haili Zhang et al. GENETICS
- Acrolein scavengers, cysteamine and N-benzylhydroxylamine, reduces the mouse liver damage after acetaminophen overdose
- (2016) Ryo KOYAMA et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- Decoding ALS: from genes to mechanism
- (2016) J. Paul Taylor et al. NATURE
- The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives
- (2016) Stephanie Cherqui et al. Nature Reviews Nephrology
- Why Have Clinical Trials of Antioxidants to Prevent Neurodegeneration Failed? - A Cellular Investigation of Novel Phenothiazine-Type Antioxidants Reveals Competing Objectives for Pharmaceutical Neuroprotection
- (2016) Maike J. Ohlow et al. PHARMACEUTICAL RESEARCH
- Transcriptional control of amino acid homeostasis is disrupted in Huntington’s disease
- (2016) Juan I. Sbodio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Pharmacogenetic Discovery: Cystamine Protects Against Haloperidol-Induced Toxicity and Ischemic Brain Injury
- (2016) Haili Zhang et al. GENETICS
- Modes of Physiologic H2S Signaling in the Brain and Peripheral Tissues
- (2015) Bindu D. Paul et al. ANTIOXIDANTS & REDOX SIGNALING
- Schizophrenia
- (2015) René S. Kahn et al. Nature Reviews Disease Primers
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- The Role of Oxidative Stress in Neurodegenerative Diseases
- (2015) Geon Ha Kim et al. Experimental Neurobiology
- Mild to moderate Alzheimer dementia with insufficient neuropathological changes
- (2014) Alberto Serrano-Pozo et al. ANNALS OF NEUROLOGY
- Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
- (2014) Daniela De Stefano et al. Autophagy
- Acrolein, a highly toxic aldehyde generated under oxidative stress in vivo, aggravates the mouse liver damage after acetaminophen overdose
- (2014) Tomoya ARAI et al. BIOMEDICAL RESEARCH-TOKYO
- Cystamine Improves Functional Recovery via Axon Remodeling and Neuroprotection after Stroke in Mice
- (2014) Pei-Cheng Li et al. CNS Neuroscience & Therapeutics
- Different concentrations of cysteamine and ergothioneine improve microscopic and oxidative parameters in ram semen frozen with a soybean lecithin extender
- (2014) Abozar Najafi et al. CRYOBIOLOGY
- A phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease
- (2014) Adriana Prundean et al. MOVEMENT DISORDERS
- Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington’s disease
- (2014) Bindu D. Paul et al. NATURE
- Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?
- (2014) Torbjörn Persson et al. Oxidative Medicine and Cellular Longevity
- Genetic Deletion of Transglutaminase 2 Does Not Rescue the Phenotypic Deficits Observed in R6/2 and zQ175 Mouse Models of Huntington's Disease
- (2014) Liliana B. Menalled et al. PLoS One
- Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia
- (2014) Peter F. Buckley et al. SCHIZOPHRENIA RESEARCH
- Effects of Cystamine on antioxidant activities and regulatory T cells in lupus-prone mice
- (2013) Tsai-Ching Hsu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1
- (2013) Miki Oono et al. JOURNAL OF NEUROCHEMISTRY
- Effect of Age at Treatment on Cognitive Performance in Patients with Cystinosis
- (2013) Lisa Viltz et al. JOURNAL OF PEDIATRICS
- Cysteamine Modulates Oxidative Stress and Blocks Myofibroblast Activity in CKD
- (2013) D. M. Okamura et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oxidizing Effects of Exogenous Stressors in Huntington’s Disease Knock-in Striatal Cells—Protective Effect of Cystamine and Creatine
- (2013) Márcio Ribeiro et al. TOXICOLOGICAL SCIENCES
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- H2S signalling through protein sulfhydration and beyond
- (2012) Bindu D. Paul et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia
- (2012) A. B. Balasubramanian et al. NEUROLOGY
- Regulation of the activities of the mammalian transglutaminase family of enzymes
- (2012) Cornelius Klöck et al. PROTEIN SCIENCE
- Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice
- (2011) Ammar Kutiyanawalla et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of Cystamine on Blood Pressure and Vascular Characteristics in Spontaneously Hypertensive Rats
- (2011) M. Engholm et al. JOURNAL OF VASCULAR RESEARCH
- Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway
- (2011) Jean-Christophe Roux et al. NEUROBIOLOGY OF DISEASE
- Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment
- (2011) A. Minarini et al. NEUROPHARMACOLOGY
- Cysteamine Attenuates the Decreases in TrkB Protein Levels and the Anxiety/Depression-Like Behaviors in Mice Induced by Corticosterone Treatment
- (2011) Ammar Kutiyanawalla et al. PLoS One
- Cysteamine, the Molecule Used To Treat Cystinosis, Potentiates the Antimalarial Efficacy of Artemisinin
- (2010) G. Min-Oo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice
- (2010) Linjuan Sun et al. BRAIN RESEARCH
- Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription
- (2010) Marcus J. Calkins et al. EXPERIMENTAL NEUROLOGY
- Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium
- (2010) Gundula Min-Oo et al. EXPERIMENTAL PARASITOLOGY
- Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease
- (2010) B. R. Underwood et al. HUMAN MOLECULAR GENETICS
- Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases
- (2010) Mélanie Bousquet et al. JOURNAL OF NEUROCHEMISTRY
- Cystamine and intrabody co-treatment confers additional benefits in a fly model of Huntington's disease
- (2010) S.F. Bortvedt et al. NEUROBIOLOGY OF DISEASE
- Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases
- (2010) C. Gibrat et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cystamine Suppresses Polyalanine Toxicity in a Mouse Model of Oculopharyngeal Muscular Dystrophy
- (2010) J. E. Davies et al. Science Translational Medicine
- Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism
- (2009) John T. Pinto et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor
- (2009) C. Gibrat et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Why Have Antioxidants Failed in Clinical Trials?
- (2008) Steven R. Steinhubl AMERICAN JOURNAL OF CARDIOLOGY
- Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease
- (2008) Edward C. Stack et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex
- (2008) Anilkumar Pillai et al. JOURNAL OF NEUROCHEMISTRY
- Potential antidepressant properties of cysteamine on hippocampal BDNF levels and behavioral despair in mice
- (2008) Chu-Hsin Shieh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search